(Q46686080)

24 December 2017

title

Rosuvastatin: characterization of induced myopathy in the rat. (English)

1 reference

24 December 2017

author name string

F Russell Westwood

1

1 reference

24 December 2017

Robert C Scott

2

1 reference

24 December 2017

Alan M Marsden

3

1 reference

24 December 2017

Alison Bigley

4

1 reference

24 December 2017

Kevin Randall

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

24 December 2017

published in

Toxicologic Pathology

1 reference

24 December 2017

volume

36

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

345-352

1 reference

24 December 2017

Hindlimb muscle fiber populations of five mammals

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Molecular clues into the pathogenesis of statin-mediated muscle toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Ultrastructure of mouse striated muscle fibers following pravastatin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Comparative tolerability of the HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Muscle fibre types and their distribution in the biceps and triceps brachii of the rat and rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Statins and PPARalpha agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Statins and chronic heart failure: do we need a large-scale outcome trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Selenoprotein synthesis and side-effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Fibre size and metabolic properties of myosin heavy chain-based fibre types in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Current overview of statin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Myosin isoforms in mammalian skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Rosuvastatin: a review of its use in the management of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Simvastatin induces impairment in skeletal muscle while heart is protected.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311412

21 January 2018

Identifiers

DOI

10.1177/0192623307311412

1 reference

24 December 2017

1 reference

24 December 2017